<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="urn:hl7-org:v3" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="31e5cc40-daff-bea7-e063-6294a90a5aa4"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use Ammonia N 13 Injection safely and effectively. See full prescribing information for Ammonia N 13 Injection.
 <br/>
      <br/>
      <br/>
      <br/>
Ammonia N 13 Injection for intravenous use
 <br/>
      <br/>
Initial U.S. Approval: 2007
</title>
   <effectiveTime value="20250403"/>
   <setId root="85882893-0661-46c2-a5f2-a73f6ea4fb5a"/>
   <versionNumber value="3"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id root="1.3.6.1.4.1.519.1" extension="957704737"/>
            <name>SOFIE Co. dba SOFIE</name>
            <assignedEntity>
               <assignedOrganization>
                  <id root="1.3.6.1.4.1.519.1" extension="957704737"/>
                  <name>SOFIE Co. dba SOFIE</name>
                  <assignedEntity>
                     <assignedOrganization>
                        <id root="1.3.6.1.4.1.519.1" extension="078623800"/>
                        <name>SOFIE Co. dba SOFIE</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C91403" displayName="positron emission tomography drug production" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="49609-003" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
                  <assignedEntity>
                     <assignedOrganization>
                        <id root="1.3.6.1.4.1.519.1" extension="118258354"/>
                        <name>SOFIE Co. dba SOFIE</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C91403" displayName="positron emission tomography drug production" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="49609-003" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="31e60d68-a415-f71c-e063-6294a90a2a0f"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20250403"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="49609-003" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Ammonia

<suffix>N 13</suffix>
                        </name>
                        <formCode code="C42946" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>AMMONIA N-13</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="9"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mCi" value="260"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="9OQO0E343Z" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>AMMONIA N-13</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="9OQO0E343Z" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>AMMONIA N-13</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="30" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="49609-003-01" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43209" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="VIAL, GLASS"/>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="20110804"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA203543" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20110804"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="S1">
               <id root="23e9cbac-68f9-e8e0-e063-6394a90a01c4"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>Ammonia N 13 Injection is indicated for diagnostic Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease.</paragraph>
               </text>
               <effectiveTime value="20110122"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Ammonia N 13 Injection is a radioactive diagnostic agent for Positron Emission Tomography (PET) indicated for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease (
 
    <linkHtml href="#S1">1</linkHtml>).

   </paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S2">
               <id root="23e9cbac-68fa-e8e0-e063-6394a90a01c4"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>
                     <br/>
                  </paragraph>
               </text>
               <effectiveTime value="20130107"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Rest Imaging Study (
 
    <linkHtml href="#S2">2.1</linkHtml>): 
    <br/>
                        </paragraph>
                        <list listType="unordered">
                           <item>Aseptically withdraw Ammonia N 13 Injection from its container and administer 10-20 mCi (0.368 – 0.736 GBq) as a bolus through a catheter inserted into a large peripheral vein. 
     <br/>
                           </item>
                           <item>Start imaging 3 minutes after the injection and acquire images for a total of 10-20 minutes. 
     <br/>
                           </item>
                        </list>
                        <paragraph>Stress Imaging Study (
 
    <linkHtml href="#S2">2.2</linkHtml>):

   </paragraph>
                        <list listType="unordered">
                           <item>If a rest imaging study is performed, begin the stress imaging study 40 minutes or more after the first Ammonia N13 injection to allow sufficient isotope decay. 
     <br/>
                           </item>
                           <item>Administer a pharmacologic stress-inducing drug in accordance with its labeling. 
     <br/>
                           </item>
                           <item>Aseptically withdraw Ammonia N 13 Injection from its container and administer 10-20 mCi (0.368 – 0.736 GBq) of Ammonia N 13 Injection as a bolus at 8 minutes after the administration of the pharmacologic stress-inducing drug. 
     <br/>
                           </item>
                           <item>Start imaging 3 minutes after the Ammonia N 13 Injection and acquire images for a total of 10-20 minutes. 
     <br/>
                           </item>
                        </list>
                        <paragraph>Patient Preparation (
 
    <linkHtml href="#S2">2.3</linkHtml>): 
    <br/>
                        </paragraph>
                        <list listType="unordered">
                           <item>To increase renal clearance of radioactivity and to minimize radiation dose to the bladder, hydrate the patient before the procedure and encourage voiding as soon as each image acquisition is completed and as often as possible thereafter for at least one hour.</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section>
                     <id root="23e9cbac-68fb-e8e0-e063-6394a90a01c4"/>
                     <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
                     <title>2.1 Rest Imaging Study</title>
                     <text>
                        <list listType="unordered">
                           <item>Aseptically withdraw Ammonia N 13 Injection from its container and administer 10-20 mCi (0.368 – 0.736 GBq) as a bolus through a catheter inserted into a large peripheral vein. 
   <br/>
                           </item>
                           <item>Start imaging 3 minutes after the injection and acquire images for a total of 10-20 minutes.</item>
                        </list>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-68fc-e8e0-e063-6394a90a01c4"/>
                     <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
                     <title>2.2 Stress Imaging Study</title>
                     <text>
                        <list listType="unordered">
                           <item>If a rest imaging study is performed, begin the stress imaging study 40 minutes or more after the first Ammonia N 13 injection to allow sufficient isotope decay.</item>
                           <item>Administer a pharmacologic stress-inducing drug in accordance with its labeling. 
   <br/>
                           </item>
                           <item>Aseptically withdraw Ammonia N 13 Injection from its container and administer 10-20 mCi (0.368 – 0.736 GBq) of Ammonia N 13 Injection as a bolus at 8 minutes after the administration of the pharmacologic stress-inducing drug. 
   <br/>
                           </item>
                           <item>Start imaging 3 minutes after the Ammonia N 13 Injection and acquire images for a total of 10-20 minutes.</item>
                        </list>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-68fd-e8e0-e063-6394a90a01c4"/>
                     <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
                     <title>2.3 Patient Preparation</title>
                     <text>
                        <paragraph>To increase renal clearance of radioactivity and to minimize radiation dose to the bladder, ensure that the patient is well hydrated before the procedure  and encourage voiding as soon as a study is completed and as often as possible thereafter for at least one hour.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-68fe-e8e0-e063-6394a90a01c4"/>
                     <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
                     <title>2.4 Radiation Dosimetry</title>
                     <text>
                        <paragraph>The converted radiation absorbed doses in rem/mCi are shown in Table 1. These estimates are calculated from the Task Group of Committee 2 of the International Commission on Radiation Protection.
 
  <sup>1</sup>
                        </paragraph>
                        <table>
                           <caption>Table 1: N 13 Absorbed Radiation Dose Per Unit Activity (rem/mCi) for Adults and Pediatric Groups.</caption>
                           <col align="center" width="25%"/>
                           <col align="center" width="15%"/>
                           <col align="center" width="15%"/>
                           <col align="center" width="15%"/>
                           <col align="center" width="15%"/>
                           <col align="center" width="15%"/>
                           <thead>
                              <tr>
                                 <th align="center" styleCode="LRule Rrule Toprule">
                                    <content styleCode="bold">Organ</content>
                                 </th>
                                 <th align="center"/>
                                 <th align="center"/>
                                 <th align="center">
                                    <content styleCode="bold">Age (Years)</content>
                                 </th>
                                 <th align="center"/>
                                 <th align="center"/>
                              </tr>
                              <tr>
                                 <th align="center" styleCode="Botrule LRule Rrule"/>
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">
                                    <content styleCode="bold">Adult</content>
                                 </th>
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">
                                    <content styleCode="bold">15</content>
                                 </th>
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">
                                    <content styleCode="bold">10</content>
                                 </th>
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">
                                    <content styleCode="bold">5</content>
                                 </th>
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">
                                    <content styleCode="bold">1</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td align="center">Adrenals</td>
                                 <td align="center">0.0085</td>
                                 <td align="center">0.0096</td>
                                 <td align="center">0.016</td>
                                 <td align="center">0.025</td>
                                 <td align="center">0.048</td>
                              </tr>
                              <tr>
                                 <td align="center">Bladder wall</td>
                                 <td align="center">0.030</td>
                                 <td align="center">0.037</td>
                                 <td align="center">0.056</td>
                                 <td align="center">0.089</td>
                                 <td align="center">0.17</td>
                              </tr>
                              <tr>
                                 <td align="center">Bone surfaces</td>
                                 <td align="center">0.0059</td>
                                 <td align="center">0.0070</td>
                                 <td align="center">0.011</td>
                                 <td align="center">0.019</td>
                                 <td align="center">0.037</td>
                              </tr>
                              <tr>
                                 <td align="center">Brain</td>
                                 <td align="center">0.016</td>
                                 <td align="center">0.016</td>
                                 <td align="center">0.017</td>
                                 <td align="center">0.019</td>
                                 <td align="center">0.027</td>
                              </tr>
                              <tr>
                                 <td align="center">Breast</td>
                                 <td align="center">0.0067</td>
                                 <td align="center">0.0067</td>
                                 <td align="center">0.010</td>
                                 <td align="center">0.017</td>
                                 <td align="center">0.033</td>
                              </tr>
                              <tr>
                                 <td align="center">Stomach wall</td>
                                 <td align="center">0.0063</td>
                                 <td align="center">0.0078</td>
                                 <td align="center">0.012</td>
                                 <td align="center">0.019</td>
                                 <td align="center">0.037</td>
                              </tr>
                              <tr>
                                 <td align="center">Small intestine</td>
                                 <td align="center">0.0067</td>
                                 <td align="center">0.0081</td>
                                 <td align="center">00013</td>
                                 <td align="center">0.021</td>
                                 <td align="center">0.041</td>
                              </tr>
                              <tr>
                                 <td align="center">
                                    <sup>*</sup>ULI
   
    </td>
                                 <td align="center">0.0067</td>
                                 <td align="center">0.0078</td>
                                 <td align="center">0.013</td>
                                 <td align="center">0.021</td>
                                 <td align="center">0.037</td>
                              </tr>
                              <tr>
                                 <td align="center">
                                    <sup>**</sup>LLI
   
    </td>
                                 <td align="center">0.0070</td>
                                 <td align="center">0.0078</td>
                                 <td align="center">0.013</td>
                                 <td align="center">0.020</td>
                                 <td align="center">0.037</td>
                              </tr>
                              <tr>
                                 <td align="center">Heart</td>
                                 <td align="center">0.0078</td>
                                 <td align="center">0.0096</td>
                                 <td align="center">0.015</td>
                                 <td align="center">0.023</td>
                                 <td align="center">0.041</td>
                              </tr>
                              <tr>
                                 <td align="center">Kidneys</td>
                                 <td align="center">0.017</td>
                                 <td align="center">0.021</td>
                                 <td align="center">0.031</td>
                                 <td align="center">0.048</td>
                                 <td align="center">0.089</td>
                              </tr>
                              <tr>
                                 <td align="center">Liver</td>
                                 <td align="center">0.015</td>
                                 <td align="center">0.018</td>
                                 <td align="center">0.029</td>
                                 <td align="center">0.044</td>
                                 <td align="center">0.085</td>
                              </tr>
                              <tr>
                                 <td align="center">Lungs</td>
                                 <td align="center">0.0093</td>
                                 <td align="center">0.011</td>
                                 <td align="center">0.018</td>
                                 <td align="center">0.029</td>
                                 <td align="center">0.056</td>
                              </tr>
                              <tr>
                                 <td align="center">Ovaries</td>
                                 <td align="center">0.0063</td>
                                 <td align="center">0.0085</td>
                                 <td align="center">0.014</td>
                                 <td align="center">0.021</td>
                                 <td align="center">0.041</td>
                              </tr>
                              <tr>
                                 <td align="center">Pancreas</td>
                                 <td align="center">0.0070</td>
                                 <td align="center">0.0085</td>
                                 <td align="center">0.014</td>
                                 <td align="center">0.021</td>
                                 <td align="center">0.041</td>
                              </tr>
                              <tr>
                                 <td align="center">Red marrow</td>
                                 <td align="center">0.0063</td>
                                 <td align="center">0.0078</td>
                                 <td align="center">0.012</td>
                                 <td align="center">0.020</td>
                                 <td align="center">0.037</td>
                              </tr>
                              <tr>
                                 <td align="center">Spleen</td>
                                 <td align="center">0.0093</td>
                                 <td align="center">0.011</td>
                                 <td align="center">0.019</td>
                                 <td align="center">0.030</td>
                                 <td align="center">0.056</td>
                              </tr>
                              <tr>
                                 <td align="center">Testes</td>
                                 <td align="center">0.0067</td>
                                 <td align="center">0.0070</td>
                                 <td align="center">0.011</td>
                                 <td align="center">0.018</td>
                                 <td align="center">0.035</td>
                              </tr>
                              <tr>
                                 <td align="center">Thyroid</td>
                                 <td align="center">0.0063</td>
                                 <td align="center">0.0081</td>
                                 <td align="center">0.013</td>
                                 <td align="center">0.021</td>
                                 <td align="center">0.041</td>
                              </tr>
                              <tr>
                                 <td align="center">Uterus</td>
                                 <td align="center">0.0070</td>
                                 <td align="center">0.0089</td>
                                 <td align="center">0.014</td>
                                 <td align="center">0.023</td>
                                 <td align="center">0.041</td>
                              </tr>
                              <tr>
                                 <td align="center">Other tissues</td>
                                 <td align="center">0.0059</td>
                                 <td align="center">0.0070</td>
                                 <td align="center">0.011</td>
                                 <td align="center">0.018</td>
                                 <td align="center">0.035</td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>*Upper large intestine, **Lower large intestine</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-68ff-e8e0-e063-6394a90a01c4"/>
                     <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
                     <title>2.5 Drug Handling</title>
                     <text>
                        <list listType="unordered">
                           <item>Inspect Ammonia N 13 Injection visually for particulate matter and discoloration before administration, whenever solution and container permit.</item>
                           <item>Do not administer Ammonia N 13 Injection containing particulate matter or discoloration; dispose of these unacceptable or unused preparations in a safe manner, in compliance with applicable regulations. 
   <br/>
                           </item>
                           <item>Wear waterproof gloves and effective shielding when handling Ammonia N 13 Injection. 
   <br/>
                           </item>
                           <item>Use aseptic technique to maintain sterility during all operations involved in the manipulation and administration of Ammonia N 13 Injection. The contents of each vial are sterile and non-pyrogenic. 
   <br/>
                           </item>
                           <item>Use appropriate safety measures, including shielding, consistent with proper patient management to avoid unnecessary radiation exposure to the patient, occupational workers, clinical personnel, and other persons. 
   <br/>
                           </item>
                           <item>Radiopharmaceuticals should be used by or under the control of physicians who are qualified by specific training and experience in the safe use and handling of radionuclides, and whose experience and training have been approved by the appropriate governmental agency authorized to license the use of radionuclides. 
   <br/>
                           </item>
                           <item>Before administration of Ammonia N 13 Injection, assay the dose in a properly calibrated dose calibrator.</item>
                        </list>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Lc4fa27e9-bfbf-4871-ad2f-e4cd8ab84248">
               <id root="23e9cbac-6900-e8e0-e063-6394a90a01c4"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS</title>
               <text>
                  <paragraph>Glass vial (30 mL) containing 0.14-9.62 GBq (3.75-260 mCi/mL) of Ammonia N 13 Injection in aqueous 0.9 % sodium chloride solution (approximately 5 mL volume) that is suitable for intravenous administration.</paragraph>
               </text>
               <effectiveTime value="20120918"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Glass vial (30 mL) containing 0.14-9.62 GBq (3.75-260 mCi/mL) of Ammonia N 13 Injection in aqueous 0.9 % sodium chloride solution (approximately 5 mL volume) that is suitable for intravenous administration.</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S4">
               <id root="23e9cbac-6901-e8e0-e063-6394a90a01c4"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS</title>
               <text>
                  <paragraph>None</paragraph>
               </text>
               <effectiveTime value="20110122"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>None (
 
    <linkHtml href="#S4">4</linkHtml>)

   </paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S5">
               <id root="23e9cbac-6902-e8e0-e063-6394a90a01c4"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS</title>
               <text>
                  <paragraph>
                     <br/>
                  </paragraph>
               </text>
               <effectiveTime value="20110122"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Ammonia N 13 Injection may increase the risk of cancer. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker (
 
    <linkHtml href="#S5">5</linkHtml>).

   </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section>
                     <id root="23e9cbac-6903-e8e0-e063-6394a90a01c4"/>
                     <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
                     <title>5.1 Radiation Risks</title>
                     <text>
                        <paragraph>Ammonia N 13 Injection may increase the risk of cancer. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker
 
  <content styleCode="italics">[see Dosage and Administration (2.4)]</content>.

 </paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="id_link_31e63aa7-674b-ffcf-e063-6294a90a5590">
               <id root="31e63aa7-674a-ffcf-e063-6294a90a5590"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS</title>
               <text>
                  <paragraph>No adverse reactions have been reported for Ammonia N 13 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems. However, the completeness of these sources is not known.</paragraph>
               </text>
               <effectiveTime value="20200508"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>No adverse reactions have been reported for Ammonia N 13 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting system(6).
    <br/>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact SOFIE Co. at 1-800-207-1865 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section>
               <id root="23e9cbac-6905-e8e0-e063-6394a90a01c4"/>
               <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
               <title>7 DRUG INTERACTIONS</title>
               <text>
                  <paragraph>The possibility of interactions of Ammonia N 13 Injection with other drugs taken by patients undergoing PET imaging has not been studied.</paragraph>
               </text>
               <effectiveTime value="20110122"/>
            </section>
         </component>
         <component>
            <section ID="S8">
               <id root="23e9cbac-6906-e8e0-e063-6394a90a01c4"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS</title>
               <text>
                  <paragraph>
                     <br/>
                  </paragraph>
               </text>
               <effectiveTime value="20110122"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>It is not known whether this drug is excreted in human milk. Alternatives to breastfeeding (e.g. using stored breast milk or infant formula) should be used for 2 hours (&gt;10 half-lives of radioactive decay for N 13 isotope) after administration of Ammonia N 13 Injection (
  
     <linkHtml href="#S8">8.3</linkHtml>). 
     <br/>
                           </item>
                           <item>The safety and effectiveness of Ammonia N 13 Injection has been established in pediatric patients (
  
     <linkHtml href="#S8">8.4</linkHtml>).
 
    </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section>
                     <id root="23e9cbac-6907-e8e0-e063-6394a90a01c4"/>
                     <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
                     <title>8.1 Pregnancy</title>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Pregnancy Category C</content>
                        </paragraph>
                        <paragraph>Animal reproduction studies have not been conducted with Ammonia N 13 Injection.  It is also not known whether Ammonia N 13 Injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.  Ammonia N 13 Injection should be given to a pregnant woman only if clearly needed.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-6908-e8e0-e063-6394a90a01c4"/>
                     <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
                     <title>8.3 Nursing Mothers</title>
                     <text>
                        <paragraph>It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for radiation exposure to nursing infants from Ammonia N 13 Injection, use alternative infant nutrition sources (e.g. stored breast milk or infant formula) for 2 hours (&gt;10 half-lives of radioactive decay for N 13 isotope) after administration of the drug or avoid use of the drug, taking into account the importance of the drug to the mother.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-6909-e8e0-e063-6394a90a01c4"/>
                     <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
                     <title>8.4 Pediatric Use</title>
                     <text>
                        <paragraph>The safety and effectiveness of Ammonia N 13 Injection has been established in pediatric patients based on known metabolism of ammonia, radiation dosimetry in the pediatric population, and clinical studies in adults
 
  <content styleCode="italics">[see Dosage and Administration (2.4)]. 
   <br/>
                           </content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="L551f9a32-13e8-4037-a6b6-8af33a756dcd">
               <id root="23e9cbac-690a-e8e0-e063-6394a90a01c4"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION</title>
               <text/>
               <effectiveTime value="20130107"/>
               <component>
                  <section ID="L6160cf4b-6d17-4193-95aa-48a02dd7e6ed">
                     <id root="23e9cbac-690b-e8e0-e063-6394a90a01c4"/>
                     <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
                     <title>11.1 Chemical Characteristics</title>
                     <text>
                        <paragraph>Ammonia N 13 Injection is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging. The active ingredient, [
 
  <sup>13</sup>N] ammonia, has the molecular formula of
 
  <sup>13</sup>NH
 
  <sub>3</sub>with a molecular weight of 16.02, and has the following chemical structure:

 </paragraph>
                        <paragraph>
                           <renderMultiMedia referencedObject="Lf3b23717-68f7-4e2a-9854-5741049e9ce1"/>
                        </paragraph>
                        <paragraph>Ammonia N 13 Injection is provided as a ready to use sterile, pyrogen-free, clear and colorless solution. Each mL of the solution contains between 0.14-9.62 GBq (3.75-260 mCi) of [
 
  <sup>13</sup>N] ammonia, at the end of synthesis (EOS) reference time, in 0.9% aqueous sodium chloride. The pH of the solution is between 4.5 to 7.5. The recommended dose of radioactivity (10-20 mCi) is associated with a theoretical mass dose of 0.5-1.0 picomoles (8.47-16.94 picograms) of ammonia.

 </paragraph>
                     </text>
                     <effectiveTime value="20130102"/>
                     <component>
                        <observationMedia ID="Lf3b23717-68f7-4e2a-9854-5741049e9ce1">
                           <text>Chemical Structure</text>
                           <value mediaType="image/jpeg" xsi:type="ED">
                              <reference value="chemical_structure.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="L1371b67d-50a5-4978-98ae-88cb34d46e5d">
                     <id root="23e9cbac-690c-e8e0-e063-6394a90a01c4"/>
                     <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
                     <title>11.2 Physical Characteristics</title>
                     <text>
                        <paragraph>Nitrogen N13 decays by emitting positron to Carbon C13 (stable) and has a physical half-life of 9.96 minutes. The principal photons useful for imaging are the dual 511 keV gamma photons that are produced and emitted simultaneously in opposite direction when the positron interacts with an electron (Table 2).</paragraph>
                        <table>
                           <caption>Table 2: Principal Radiation Emission Data for Nitrogen 13</caption>
                           <col align="center" width="33%"/>
                           <col align="center" width="33%"/>
                           <col align="center" width="33%"/>
                           <thead>
                              <tr styleCode="First Last">
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">Radiation/Emission</th>
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">% per Disintegration</th>
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">Mean Energy</th>
                              </tr>
                           </thead>
                           <tfoot>
                              <tr styleCode="First Last">
                                 <td align="left">
                                    <sup>*</sup>Produced by positron annihilation
   
    </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">Positron (β+)</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">100</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">1190 keV (Max.)</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">Gamma (±)
    
     <sup>*</sup>
                                 </td>
                                 <td align="center" styleCode="Botrule LRule Rrule">200</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">511.0 keV</td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>The specific gamma ray constant (point source air kerma coefficient) for nitrogen N13 is 5.9 R/hr/mCi (1.39 x 10
 
  <sup>-6</sup>Gy/hr/kBq) at 1 cm. The half-value layer (HVL) of lead (Pb) for 511 keV photons is 4 mm. Selected coefficients of attenuation are listed in Table 3 as a function of lead shield thickness. For example, the use of 39 mm thickness of lead will attenuate the external radiation by a factor of about 1000.

 </paragraph>
                        <paragraph/>
                        <table>
                           <caption>Table 3:Radiation Attenuation of 511 keV Photons by Lead (Pb) Shielding</caption>
                           <col align="left" width="50%"/>
                           <col align="left" width="50%"/>
                           <thead>
                              <tr styleCode="First Last">
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">Shield Thickness (Pb) mm</th>
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">Coefficient of Attenuation</th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">0</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.00</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">4</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.50</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">8</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.25</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">13</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.10</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">26</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.01</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">39</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.001</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">52</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.0001</td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Table 4 lists fractions remaining at selected time intervals from the calibration time. This information may be used to correct for physical decay of the radionuclide.</paragraph>
                        <table>
                           <caption>Table 4: Physical Decay Chart for Nitrogen N 13</caption>
                           <col align="center" width="50%"/>
                           <col align="center" width="50%"/>
                           <thead>
                              <tr styleCode="First Last">
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">Minutes</th>
                                 <th align="center" styleCode="Botrule LRule Rrule Toprule">Fraction Remaining</th>
                              </tr>
                           </thead>
                           <tfoot>
                              <tr styleCode="First Last">
                                 <td align="left">
                                    <sup>*</sup>calibration time
   
    </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">0
    
     <sup>*</sup>
                                 </td>
                                 <td align="center" styleCode="Botrule LRule Rrule">1.000</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">5</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.706</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">10</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.499</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">15</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.352</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">20</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.249</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">25</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.176</td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Botrule LRule Rrule">30</td>
                                 <td align="center" styleCode="Botrule LRule Rrule">0.124</td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph/>
                     </text>
                     <effectiveTime value="20130107"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="23e9cbac-690d-e8e0-e063-6394a90a01c4"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>
                     <br/>
                  </paragraph>
               </text>
               <effectiveTime value="20110122"/>
               <component>
                  <section>
                     <id root="23e9cbac-690e-e8e0-e063-6394a90a01c4"/>
                     <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
                     <title>12.1 Mechanism of Action</title>
                     <text>
                        <paragraph>Ammonia N 13 Injection is a radiolabeled analog of ammonia that is distributed to all organs of the body after intravenous administration.  It is extracted from the blood in the coronary capillaries into the myocardial cells where it is metabolized to glutamine N 13 and retained in the cells.  The presence of ammonia N 13 and glutamine N 13 in the myocardium allows for PET imaging of the myocardium.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-690f-e8e0-e063-6394a90a01c4"/>
                     <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
                     <title>12.2 Pharmacodynamics</title>
                     <text>
                        <paragraph>Following intravenous injection, ammonia N 13 enters the myocardium through the coronary arteries.  The PET technique measures myocardial blood flow based on the assumption of a three-compartmental disposition of intravenous ammonia N 13 in the myocardium.  In this model, the value of the rate constant, which represents the delivery of blood to myocardium, and the fraction of ammonia N 13 extracted into the myocardial cells, is a measure of myocardial blood flow. Optimal PET imaging of the myocardium is generally achieved between 10 to 20 minutes after administration.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-6910-e8e0-e063-6394a90a01c4"/>
                     <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
                     <title>12.3 Pharmacokinetics</title>
                     <text>
                        <paragraph>Following intravenous injection, Ammonia N 13 Injection is cleared from the blood with a biologic half-life of about 2.84 minutes (effective half-life of about 2.21 minutes).  In the myocardium, its biologic half-life has been estimated to be less than 2 minutes (effective half-life less than 1.67 minutes). 
  <br/>
                        </paragraph>
                        <paragraph>The mass dose of Ammonia N 13 Injection is very small as compared to the normal range of ammonia in the blood (0.72-3.30 mg) in a healthy adult man
 
  <content styleCode="italics">[see Description (11.1)]</content>. 
  <br/>
                        </paragraph>
                        <paragraph>Plasma protein binding of ammonia N 13 or its N 13 metabolites has not been studied. 
  <br/>
                        </paragraph>
                        <paragraph>Ammonia N 13 undergoes a five-enzyme step metabolism in the liver to yield urea N 13 (the main circulating metabolite).  It is also metabolized to glutamine N 13 (the main metabolite in tissues) by glutamine synthesis in the skeletal muscles, liver, brain, myocardium, and other organs.  Other metabolites of ammonia N 13 include small amounts of N 13 amino acid anions (acidic amino acids) in the forms of glutamate N 13 or aspartate N 13. 
  <br/>
                        </paragraph>
                        <paragraph>Ammonia N 13 is eliminated from the body by urinary excretion mainly as urea N 13. 
  <br/>
                        </paragraph>
                        <paragraph>The pharmacokinetics of Ammonia N 13 Injection have not been studied in renally impaired, hepatically impaired, or pediatric patients.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="23e9cbac-6911-e8e0-e063-6394a90a01c4"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13 NONCLINICAL TOXICOLOGY</title>
               <text>
                  <paragraph>
                     <br/>
                  </paragraph>
               </text>
               <effectiveTime value="20110122"/>
               <component>
                  <section>
                     <id root="23e9cbac-6912-e8e0-e063-6394a90a01c4"/>
                     <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph>Long term animal studies have not been performed to evaluate the carcinogenic potential of Ammonia N 13 Injection.  Genotoxicity assays and impairment of male and female fertility studies with Ammonia N 13 Injection have not been performed.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Laa4e9bd7-98d6-456d-955a-a5aa5da19bd3">
               <id root="23e9cbac-6913-e8e0-e063-6394a90a01c4"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14 CLINICAL STUDIES</title>
               <text>
                  <paragraph>In a descriptive, prospective, blinded image interpretation study
 
  <sup>2</sup>of adult patients with known or suspected coronary artery disease, myocardial perfusion deficits in stress and rest PET images obtained with Ammonia N 13 (N=111) or Rubidium 82 (N=82) were compared to changes in stenosis flow reserve (SFR) as determined by coronary angiography. The principal outcome of the study was the evaluation of PET defect severity relative to SFR.

 </paragraph>
                  <paragraph>PET perfusion defects at rest and stress for seven cardiac regions (anterior, apical, anteroseptal, posteroseptal, anterolateral, posterolateral, and inferior walls) were graded on a 0 to 5 scale defined as normal (0), possible (1), probable (2), mild (3), moderate (4), and severe (5) defects. Coronary angiograms were used to measure absolute and relative stenosis dimensions and to calculate stenosis flow reserve defined as the maximum value of flow at maximum coronary vasodilatation relative to rest flow under standardized hemodynamic conditions. SFR scores ranged from 0 (total occlusion) to 5 (normal)</paragraph>
                  <paragraph>With increasing impairment of flow reserve, the subjective PET defect severity increased. A PET defect score of 2 or higher was positively correlated with flow reserve impairment (SFR&lt;3).</paragraph>
               </text>
               <effectiveTime value="20130104"/>
            </section>
         </component>
         <component>
            <section>
               <id root="23e9cbac-6914-e8e0-e063-6394a90a01c4"/>
               <code code="34093-5" codeSystem="2.16.840.1.113883.6.1" displayName="REFERENCES SECTION"/>
               <title>15 REFERENCES</title>
               <text>
                  <list listType="ordered">
                     <item>Annals of the ICRP.  Publication 53. Radiation dose to patients from radiopharmaceuticals.  New York: Pergamon Press, 1988. 
   <br/>
                     </item>
                     <item>Demer, L.L.K.L.Gould, R.A.Goldstein, R.L.Kirkeeide, N.A.Mullani, R.W. Smalling, A.Nishikawa, and M.E.Merhige. Assessment of coronary artery disease severity by PET: Comparison with quantitative arteriography in 193 patients.  Circulation 1989; 79: 825-35.</item>
                  </list>
               </text>
               <effectiveTime value="20110122"/>
            </section>
         </component>
         <component>
            <section ID="Ld53ed2cf-d49a-4fc1-86c3-fded4c52ea26">
               <id root="23e9cbac-6915-e8e0-e063-6394a90a01c4"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED</title>
               <text>
                  <paragraph>Ammonia N 13 Injection is packaged in 30 mL multiple dose glass vial containing between 0.14-9.62 GBq/mL (3.75-260 mCi/mL) of [
 
  <sup>13</sup>N] ammonia, at the end of synthesis (EOS) reference time, in 0.9% sodium chloride injection solution in approximately 5 mL volume. The recommended dose of radioactivity (10-20 mCi) is associated with a theoretical mass dose of 0.5-1.0 picomoles (8.47-16.94 picograms) of Ammonia.

 </paragraph>
                  <paragraph>Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). Use the solution within 60 minutes of the End of Synthesis (EOS) calibration.</paragraph>
               </text>
               <effectiveTime value="20120918"/>
            </section>
         </component>
         <component>
            <section>
               <id root="23e9cbac-6916-e8e0-e063-6394a90a01c4"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION</title>
               <text>
                  <paragraph>
                     <br/>
                  </paragraph>
               </text>
               <effectiveTime value="20110122"/>
               <component>
                  <section>
                     <id root="23e9cbac-6917-e8e0-e063-6394a90a01c4"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title>17.1 Pre-study Hydration</title>
                     <text>
                        <paragraph>Instruct patients to drink plenty of water or other fluids (as tolerated) in the 4 hours before their PET study.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-6918-e8e0-e063-6394a90a01c4"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title>17.2 Post-study Voiding</title>
                     <text>
                        <paragraph>Instruct patients to void after completion of each image acquisition session and as often as possible for one hour after the PET scan ends.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="23e9cbac-6919-e8e0-e063-6394a90a01c4"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title>17.3 Post-study Breastfeeding Avoidance</title>
                     <text>
                        <paragraph>Instruct nursing patients to substitute stored breast milk or infant formula for breast milk for 2 hours after administration of Ammonia N 13 Injection.</paragraph>
                     </text>
                     <effectiveTime value="20110122"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="L7b09dd90-3140-4120-8a13-9d3506336283">
               <id root="23e9cbac-691a-e8e0-e063-6394a90a01c4"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <title/>
               <text>
                  <table width="100%" border="2">
                     <caption/>
                     <tbody>
                        <tr styleCode="First Last">
                           <td>
                              <paragraph>Manufactured and distributed by:</paragraph>
                              <paragraph/>
                              <paragraph>SOFIE Co. dba SOFIE</paragraph>
                              <paragraph>21000 Atlantic Blvd. Suite 730</paragraph>
                              <paragraph>Dulles, VA 20166</paragraph>
                              <paragraph>USA</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph/>
               </text>
               <effectiveTime value="20200508"/>
            </section>
         </component>
         <component>
            <section ID="Le7e18c39-bb37-4f73-84d5-6e206a8b6707">
               <id root="247513db-6522-64c8-e063-6394a90ae7c9"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">LABEL ON CLOSURE VIAL AND LEAD PIG CONTAINERS</content>
                  </paragraph>
                  <paragraph/>
                  <paragraph>NDC# 49609-003-01</paragraph>
                  <paragraph>3.75-260 mCi.mL (@EOS*)</paragraph>
                  <paragraph>Multiple-Dose Vial</paragraph>
                  <paragraph>Sterile, Non-pyrogenic</paragraph>
                  <paragraph>(Expires 1 hour(s) after EOS*)</paragraph>
                  <paragraph>
                     <content styleCode="bold">Ammonia N 13 injection</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Diagnostic - For Intravenous Use Only</content>
                  </paragraph>
                  <paragraph>Exp.:  Vol.: ml</paragraph>
                  <paragraph>Activity @ (EOS*) Date/Time:</paragraph>
                  <paragraph>Concentration:  mCi/ml</paragraph>
                  <paragraph>
                     <content styleCode="bold">Each ml contains:</content>
                  </paragraph>
                  <paragraph>0.14-9.62 GBq (3.75-260 mCi) of no-carrier added Ammonia N-13 @ EOS* in 0.9% sodium Chloride Injection.</paragraph>
                  <paragraph>Do not use if cloudy or if it contains particu-late matter. *EOS = End of Synthesis</paragraph>
                  <paragraph>CAUTION: RADIOACTIVE MATERIAL</paragraph>
                  <paragraph>
                     <content styleCode="bold">R
   <sub>x</sub> Only  Lot #
  </content>
                  </paragraph>
                  <paragraph>Store at 25ºC (77ºF) (see insert). Store upright in a shielded container. Aseptically withdraw and handle doses.</paragraph>
                  <paragraph>[13N] Half-Life = 9.96 minutes. Calculated correct dosage from date and time of calibration.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Manufactured by:</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">SOFIE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">8285 El Rio suite 160, Houston, TX 77054</content>
                  </paragraph>
                  <paragraph>(radioactive symbol)</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="img_24751b17-3cb1-5da1-e063-6394a90a46a6"/>
                  </paragraph>
                  <paragraph>LABEL ON CLOSURE VIAL AND LEAD PIG CONTAINERS</paragraph>
                  <paragraph>NDC# 49609-003-01</paragraph>
                  <paragraph>3.75-260 mCi.mL (@EOS*)</paragraph>
                  <paragraph>Multiple-Dose Vial</paragraph>
                  <paragraph>Sterile, Non-pyrogenic</paragraph>
                  <paragraph>(Expires 1 hour(s) after EOS*)</paragraph>
                  <paragraph>Ammonia N 13 injection</paragraph>
                  <paragraph>Diagnostic - For Intravenous Use Only</paragraph>
                  <paragraph>Exp.:  Vol.: ml</paragraph>
                  <paragraph>Activity @ (EOS*) Date/Time:</paragraph>
                  <paragraph>Concentration:  mCi/ml</paragraph>
                  <paragraph>Each ml contains:</paragraph>
                  <paragraph>0.14-9.62 GBq (3.75-260 mCi) of no-carrier added Ammonia N-13 @ EOS* in 0.9% sodium Chloride Injection.</paragraph>
                  <paragraph>Do not use if cloudy or if it contains particu-late matter. *EOS = End of Synthesis</paragraph>
                  <paragraph>CAUTION: RADIOACTIVE MATERIAL</paragraph>
                  <paragraph>Rx Only  Lot #</paragraph>
                  <paragraph>Store at 25ºC (77ºF) (see insert). Store upright in a shielded container. Aseptically withdraw and handle doses.</paragraph>
                  <paragraph>[13N] Half-Life = 9.96 minutes. Calculated correct dosage from date and time of calibration.</paragraph>
                  <paragraph>Manufactured by:</paragraph>
                  <paragraph>SOFIE Co. dba SOFIE 64 Medical Center Drive,</paragraph>
                  <paragraph>Room B042, Morgantown, WV, 26506</paragraph>
                  <paragraph>(radioactive symbol)</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="img_2475211f-1202-1384-e063-6294a90a5f85"/>
                  </paragraph>
                  <paragraph/>
                  <paragraph/>
               </text>
               <effectiveTime value="20200507"/>
               <component>
                  <observationMedia ID="img_24751b17-3cb1-5da1-e063-6394a90a46a6">
                     <text>Houston</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Ammonia-N-13-Injection-Sofie-Houston.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="img_2475211f-1202-1384-e063-6294a90a5f85">
                     <text>Morgantown</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Ammonia-N-13-Injection-Sofie-Morgantown.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>